1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication
(
- Contribution to journal › Article
- 2011
-
Mark
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
(
- Contribution to journal › Article
- 2009
-
Mark
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
(
- Contribution to journal › Article
- 2008
-
Mark
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
(
- Contribution to journal › Article
- 2005
-
Mark
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
(
- Contribution to journal › Article
- 2004
-
Mark
Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables
(
- Contribution to journal › Article
- 2003
-
Mark
Lack of HIN-1 methylation in BRCAl-linked and "BRCA1-like" breast tumors
(
- Contribution to journal › Article
-
Mark
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies
(
- Contribution to journal › Article
- 2002
-
Mark
A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes
(
- Contribution to journal › Article